Table 1 Demographic and virologic characteristics of patients vaccinated with BNT162b2 with documented SARS-CoV-2 infection through positive RT-PCR on nasopharyngeal swab
ID | Age | Sex | Previous COVID-19 | Days between vaccination and serology | Anti-S1 antibodies (U/mL) | Days between vaccination and symptoms | Days between vaccination and positive swab | Ct | Lineage |
|---|---|---|---|---|---|---|---|---|---|
1 | 29 | M | Unknown | 24 | 2974 | No symptoms | 36 | 41 | Unknown |
2 | 28 | F | Unknown | 46 | 460 | No symptoms | 29 | 36.5 | Unknown |
3 | 29 | M | No | 82 | 866 | 26 | 24 | 21.8 | B.1.351 |
4 | 28 | F | Unknown | 63 | 3787 | No symptoms | 29 | 14.2 | B.1.1.241 |
5 | 60 | M | Unknown | 36 | 353 | 63 | 65 | 16.5 | C.36 |
6 | 28 | F | Unknown | 35 | 3838 | No symptoms | 72 | 21.6 | C.36 |
7 | 38 | F | Unknown | 37 | 1902 | 50 | 51 | 17.8 | P.1 |
8 | 22 | F | Unknown | 65 | 1925 | No symptoms | 66 | 34.5 | Unknown |
9 | 46 | M | No | 34 | 637 | 58 | 58 | 16.6 | B.1.1.7 |
10 | 31 | M | Unknown | 36 | 1493 | 34 | 35 | 19.8 | B.1.525 |
11 | 57 | M | Unknown | 37 | 162 | No symptoms | 70 | 41.9 | Unknown |
12 | 39 | F | Yes | 36 | > 7500 | 93 | 95 | 39.6 | Unknown |
13 | 66 | M | No | 40 | 1115 | No symptoms | 109 | 20.4 | C.11 |
14 | 48 | F | Unknown | 28 | 2790 | No symptoms | 49 | 39.4 | Unknown |
15 | 26 | F | Unknown | 34 | 1005 | 55 | 55 | 14.1 | B.1.177.7 |